STERIS Q1 FY2025 revenue $1.3B (+8%), adjusted EPS $2.03; guidance reiterated

STERIS plc

2025-Q1 EPS reported $1.46 revenue$1,279,502,000

Total revenue from continuing ops $1.3B, up 8% YoY; constant currency organic revenue up 6%.
As-reported EPS $1.41 (from $1.31), adjusted EPS $2.03 (from $1.84).
Healthcare revenue +10% to $901.2M; AST +7% to $249.8M; Life Sciences -2% to $128.5M due to CECS divestiture.
Segment operating income all up: Healthcare $216.9M, AST $117.7M, Life Sciences $52.6M.
FY2025 guidance reaffirmed: rev growth 6.5-7.5%, adjusted EPS $9.05-$9.25, free cash flow ~$700M.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.